Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Español Near me My list Help
US Patient GuideUSA
Surprise me
Prescription medicine · generic available

Enalaprilat

Also listed by the FDA as: enalaprilat · enalaprilat dihydrate

Full FDA label All drugs

Official FDA data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the drug label, the NDC Directory, Drugs@FDA, recall reports and the drug shortage list. Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

At a glance

YesBoxed warning
None listedFDA shortage list
0Recalls (FDA reports)
3Companies
2000First FDA approval on file

Quick answers

What is Enalaprilat used for?
The FDA-approved label (Enalaprilat, Dr. Reddys Laboratories Inc, June 7, 2024) says: “Enalaprilat injection is indicated for the treatment of hypertension when oral therapy is not practical. Enalaprilat injection has been studied with only one other antihypertensive agent, furosemide, which showed approximately additive effects on blood pressure. …” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Does Enalaprilat have a boxed warning?
Yes. The FDA label for Enalaprilat has a boxed warning, the FDA’s strongest warning. Read it on the full label and ask your pharmacist.
Is there a shortage of Enalaprilat?
No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
Has Enalaprilat been recalled?
No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
Who makes Enalaprilat?
3 companies list prescription products of Enalaprilat in the FDA NDC Directory, including Dr.Reddys Laboratories Inc, Hikma Pharmaceuticals USA Inc. and HF Acquisition Co LLC, DBA HealthFirst.

What Enalaprilat is used for

Quoted from the “Indications and Usage” section of the FDA-approved label.

Enalaprilat injection is indicated for the treatment of hypertension when oral therapy is not practical. Enalaprilat injection has been studied with only one other antihypertensive agent, furosemide, which showed approximately additive effects on blood pressure. …

— FDA label: Enalaprilat, Dr. Reddys Laboratories Inc, effective June 7, 2024. Read the full label on DailyMed →

The FDA has 3 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.

Conditions named on the label

These condition names appear word for word in the label’s “Indications and Usage” text (matched with a reviewed table). Each page lists hospitals whose own websites name the condition.

High blood pressure

Related medical specialties

Cardiology

Boxed warning

A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.

This label has a boxed warning. Read it on the full label →

3 of 3 FDA labels for this medicine have a boxed warning.

Forms and how it is given

Dosage formsInjection
RouteIntravenous
Prescription products5 in the FDA NDC Directory

Companies that list this medicine

Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.

FDA approval history

  • ANDA: Abbreviated New Drug Application: how a generic version is approved.

Generic approvals (2)

Shortage status

The FDA drug shortage list does not show these products.

FDA Drug Shortages database →

Recalls

No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.

Official identifiers

RxCUI (RxNorm)1729200, 1729205
SPL set ID of the quoted label5d398da1-020c-ccb1-a775-ce8e0b29d621
FDA labels (SPL)3
FDA applications2 ANDA
Active ingredients (FDA)ENALAPRILAT

Sources

  1. FDA-approved label on DailyMed (National Library of Medicine) — Enalaprilat, Dr. Reddys Laboratories Inc, effective June 7, 2024; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
  2. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026

openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →

Report an error → · Information for medicine makers